SouthGobi Resources Ltd. (SGQRF)
USD 0.3
(0.0%)
USD 0.3
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 337.58 Million | 73.08 Million | 43.39 Million | 85.95 Million | 129.71 Million | 103.8 Million |
| Cost of Revenue | 162.99 Million | 57.76 Million | 31.3 Million | 58.65 Million | 84.4 Million | 79.83 Million |
| Gross Profit | 174.58 Million | 15.32 Million | 12.09 Million | 27.29 Million | 45.31 Million | 23.96 Million |
| Operating Expenses | 102.42 Million | 10.83 Million | 9.22 Million | 17.14 Million | 19.31 Million | 36.22 Million |
| Selling, General and Administrative Expenses | 11.42 Million | 6.49 Million | 5.4 Million | 6.23 Million | 8.74 Million | 10.4 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 91 Million | 150 Thousand | 587 Thousand | -2.29 Million | -5.41 Million | -825.63 Thousand |
| Cost and Expenses | 255.63 Million | 68.59 Million | 40.52 Million | 75.8 Million | 103.71 Million | 116.05 Million |
| Operating Income | 77.8 Million | 13.57 Million | 4.37 Million | 15.27 Million | 29.83 Million | -10.53 Million |
| Interest Expense | 46.47 Million | 39.73 Million | 36.45 Million | 28.2 Million | 24.62 Million | 24.98 Million |
| Income Tax Expense | 33.81 Million | 4.66 Million | 2.63 Million | 7.59 Million | 3.36 Million | 3.82 Million |
| Earnings before Tax | 34.72 Million | -25.75 Million | -11.73 Million | -12.49 Million | 7.56 Million | -37.29 Million |
| Net Income | 908 Thousand | -30.41 Million | -14.37 Million | -20.08 Million | 4.2 Million | -41.12 Million |
| Earnings Per Share Basic | 0.00 | -0.11 | -0.05 | -0.07 | 0.02 | -0.15 |
| Earnings Per Share Diluted | 0.00 | -0.11 | -0.05 | -0.07 | 0.02 | -0.15 |
| Weighted Average Shares Outstanding | 295.25 Million | 276.57 Million | 273.38 Million | 272.7 Million | 272.7 Million | 272.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 295.72 Million | 276.57 Million | 273.38 Million | 272.7 Million | 272.7 Million | 272.66 Million |
| Gross Margin | 0.52 | 0.21 | 0.28 | 0.32 | 0.35 | 0.23 |
| EBIT Margin | 0.25 | 0.12 | 0.21 | 0.24 | 0.37 | 0.10 |
| Profit Margin | 0.00 | -0.42 | -0.33 | -0.23 | 0.03 | -0.40 |
| EBITDA | 84.13 Million | 17.51 Million | 8.99 Million | 24.45 Million | 48.08 Million | 10.03 Million |
| Earnings Before Tax Margin | 0.23 | 0.19 | 0.10 | 0.18 | 0.23 | -0.10 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 92.8 Million | 81.8 Million | 337.58 Million | 90.95 Million | 97.97 Million | 83.24 Million |
| Cost of Revenue | 73.88 Million | 45.61 Million | 162.99 Million | 37.98 Million | 48.56 Million | 42.02 Million |
| Gross Profit | 18.92 Million | 36.18 Million | 174.58 Million | 52.96 Million | 49.41 Million | 41.21 Million |
| Operating Expenses | 4 Million | 4.3 Million | 96.78 Million | 10.57 Million | 4.99 Million | 79.48 Million |
| Selling, General and Administrative Expenses | 2.8 Million | 3.2 Million | - | 3.73 Million | 1.84 Million | 2.65 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -1.2 Million | -1.1 Million | -86.59 Million | -6.83 Million | 12 Thousand | 14 Thousand |
| Cost and Expenses | 77.89 Million | 49.92 Million | 259.77 Million | 48.56 Million | 53.56 Million | 121.5 Million |
| Operating Income | 14.91 Million | 31.88 Million | 77.8 Million | 42.39 Million | 46.34 Million | -40.45 Million |
| Interest Expense | 9.75 Million | 9.32 Million | 46.47 Million | 11.48 Million | 12.67 Million | 10.96 Million |
| Income Tax Expense | 8.58 Million | 9.74 Million | 34.43 Million | 6.69 Million | 9.45 Million | 9.08 Million |
| Earnings before Tax | 5.44 Million | 21.1 Million | 32.46 Million | 30.57 Million | 38.8 Million | -51.54 Million |
| Net Income | -2.08 Million | 12.25 Million | 908 Thousand | 24.33 Million | 29.34 Million | -60.63 Million |
| Earnings Per Share Basic | -0.01 | 0.04 | - | 0.08 | 0.10 | -0.21 |
| Earnings Per Share Diluted | -0.01 | 0.04 | - | 0.08 | 0.10 | -0.21 |
| Weighted Average Shares Outstanding | 296.18 Million | 295.65 Million | 295.25 Million | 295.27 Million | 295.27 Million | 295.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 296.18 Million | 297.64 Million | 295.72 Million | 296.78 Million | 295.27 Million | 295.22 Million |
| Gross Margin | 0.20 | 0.44 | 0.52 | 0.58 | 0.50 | 0.50 |
| EBIT Margin | 0.20 | 0.42 | - | 0.49 | 0.48 | -0.44 |
| Profit Margin | -0.02 | 0.15 | 0.00 | 0.27 | 0.30 | -0.73 |
| EBITDA | 18.55 Million | 34.34 Million | - | 44.14 Million | 46.83 Million | -36.43 Million |
| Earnings Before Tax Margin | 0.16 | 0.39 | 0.23 | 0.47 | 0.47 | -0.49 |
PHARM
EACTF
SRS
5254
BA
CHMI-PA